Back to News
Market Impact: 0.25

Guru Fundamental Report for EMR

EMRNDAQ
Company FundamentalsAnalyst InsightsCapital Returns (Dividends / Buybacks)Investor Sentiment & Positioning
Guru Fundamental Report for EMR

Validea's guru fundamental report for Emerson Electric Co (EMR) indicates the stock received a 68% rating using the Pim van Vliet Multi-Factor Investor model, which prioritizes low volatility stocks with strong momentum and high net payout yields. While EMR passed market capitalization and standard deviation tests, it was neutral on both momentum and net payout yield, leading to a 'FAIL' on its final rank for this strategy. This rating falls below the 80% threshold typically signaling investment interest within this quantitative, factor-based framework.

Analysis

Emerson Electric Co. (EMR) was evaluated using Validea's multi-factor model based on the Pim van Vliet strategy, which prioritizes low-volatility stocks exhibiting strong momentum and high net payout yields. The company scored 68%, falling short of the 80% threshold that typically indicates investment interest from this quantitative screen, resulting in a "FAIL" for its final rank. While EMR passed the model's tests for market capitalization and standard deviation, confirming its low-volatility characteristics, its performance was diluted by "NEUTRAL" ratings on both "twelve minus one momentum" and "net payout yield". This outcome, reflected in a moderately negative sentiment score of -0.4, suggests that despite its stability, EMR currently lacks the momentum and shareholder return profile sought by this specific factor-based investment strategy for identifying potentially outperforming conservative equities.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

moderately negative

Sentiment Score

-0.40

Ticker Sentiment

EMR-0.40
NDAQ0.00

Key Decisions for Investors

  • Investors following quantitative, multi-factor strategies like Pim van Vliet's should exercise caution, as EMR's failure to meet momentum and yield criteria suggests it may underperform within such frameworks.
  • The neutral rating on net payout yield indicates that while stable, EMR may not be a compelling option for investors prioritizing high current shareholder returns through dividends and buybacks.
  • Current holders who value the stock's low-volatility characteristics should monitor for catalysts that could improve its currently neutral momentum profile before considering additional investment.